Project Grant R00EB034778

Award Date 9/1/24
Completion Date 8/31/27
Dollars Obligated $249K
Federal Grant Program
93.286
Assistance Type
Project Grant
Place of Performance
Evanston, IL 60208, USA
Similar Awards
This National Science Foundation (NSF) Project Grant award for $380,074, awarded on September 1, 2024, aims to develop a platform for instrument-free, easy-to-interpret quantitative analysis of molecular biomarkers. The project will produce a general methodology adaptable to a range of molecular targets, including potential new agents. The key products to be delivered include: A "yes/no" output for quantitative measurement, enabled through stoichiometry and negative cooperativity-based...
This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), provides $447,304 to The Regents of the University of California, Berkeley (UC Berkeley) to develop a compact single-molecule assay (SIMOA) system. The objective is to create an integrated circuit chip that seamlessly combines microfluidics and electronics to enable sensitive...
This $980,779 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), aims to develop a deployable and adaptable plasmonic sensing platform for infectious disease surveillance. The key product to be delivered is a multiplexed Catalytic Surface-Enhanced Raman Scattering (SERS) sensor system capable of detecting multiple genetic...
This federal Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), provides $257,807 to the University of California, San Diego (UCSD) to develop living biosensors for rapid, point-of-care DNA diagnostics. The project aims to create biosensors that can directly analyze DNA from raw samples without extensive purification, enabling...
This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), provides $295,308 to Actoprobe LLC to develop and validate a novel class of scanning probe microscopy (SPM) probes. The goal is to dramatically improve the sensitivity and spatial resolution of scanning near-field optical microscopy (SNOM) and tip-enhanced Raman spectroscopy...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $349,566 to Biosensing Instrument Inc. to develop a Spotting-Free Nano-Oscillator Array (SFNOA) technology. The SFNOA system aims to enable high-throughput, label-free quantification of ligand binding kinetics to transmembrane proteins in their native states. Key innovations include the use of virion-displayed...
This National Science Foundation (NSF) Computer and Information Science and Engineering (CISE) Federal Grant Program (CFDA 47.070) award of $1,200,000 provides funding to the University of California, Berkeley from October 1, 2024 to September 30, 2028 to develop innovative sensing technologies that integrate DNA nanotechnology and CMOS electronics for next-generation diagnostics. The key objectives of this project grant are to: (1) develop molecular engineering techniques using DNA origami...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $304,966 to Kompass Diagnostics Inc., a small business located in Chicago, Illinois, will support the development of a portable, rapid point-of-care diagnostic device for detecting multiple blood-based biomarkers. The key objectives of this award are to: (1) develop an integrated cartridge/analyzer system that automates serum separation and buffer dilution to enable...
This federal Project Grant award, valued at $1,466,982.00 and provided by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), supports research and development of recombinase-based genetic circuits for cellular diagnostic devices, with a focus on applications in ovarian cancer detection. The key objectives are to: 1) Design a recombinase-shRNA-based digital...
This $402,222 National Science Foundation Project Grant, funded through the Engineering program (CFDA 47.041), supports the development of a new class of simple, inexpensive, portable, and rapid molecular diagnostic platforms. The awardee, University of Cincinnati, will engineer an instrument that can reliably and quickly detect infectious diseases in human samples using a combination of biochemistry, magnetism, fluid physics, and machine learning insights. Specifically, the university will...

This $249,000 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), supports the development of a novel split enzyme diagnostic platform for rapid, sensitive detection of protein and small molecule biomarkers at the point of care.

The key objectives of this 3-year project are to: 1) incorporate binding domains into a split adenylate cyclase system to enable detection of clinically relevant biomarkers, such as hepatitis C core antigen, in human sample matrices; 2) optimize the diagnostic platform components for long-term storage and develop a portable point-of-care reader; and 3) investigate the use of split adenylate cyclase and cAMP receptor protein to create an autocatalytic feedback loop for switch-like protein and small molecule sensing. If successful, this research could lead to the development of a transformative diagnostic platform broadly applicable for rapid, ultrasensitive detection of a wide range of biomarkers at the point of care.

Generated 6/24/25, 3:25 AM